课题基金 / 基金详情

TOPO-II PHOSPHORYLATION AND CELL DIFFERENTIATION

TOPO-II PHOSPHORYLATION AND CELL DIFFERENTIATION
TOPO-II 磷酸化和细胞分化
批准号:
2390798
负责人:
ANDREAS I. CONSTANTINOU
金额:
$11.63万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-04-01 至 1999-03-31

项目摘要

项目成果

ANDREAS I. CONSTANTINOU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long term research objectives of this proposal are: a) to precisely define how the activity of DNA topoisomerase II (topo II) is regulated by phosphorylation in cultured cells, and b) to identify the specific phosphorylation sites which influence cell growth and differentiation. Preliminary data strongly suggest that topo II is phosphorylated at multiple sites. Increased topo II phosphorylation is associated with elevated enzymatic activity in cell-free systems; however, in phorbol ester-treated HL-60 cells it is associated with reduced activity. Based on these observations and other phosphorylation/activity relationships, we form the hypothesis that phosphorylation of certain topo II sites renders this enzyme less active, while the phosphorylation of other sites renders it more active. To scrutinize this hypothesis, and to define the biological significance of topo II phosphorylation in cultured cells, we propose to: a) map the multiple phosphorylation sites of topo II; b) identify the specific topo II sites modulated by protein kinase activators and inhibitors, define their impact on the catalytic (strand passing) activity of the enzyme; and c) identify specific topo II determinants which, when phosphorylated, influence the ability of the enzyme to ligate DNA in the presence of topo II-reactive antitumor agents. At the end of this project, it is anticipated that the regulation of cell growth and differentiation will be further clarified and the interactions of topo II and protein kinases will be documented.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/s0959-8049(00)00017-4
发表时间: 2000-04
期刊: European journal of cancer
影响因子: 8.4
作者: [G. Salti;S. Grewal;R. Mehta;T. K. Das Gupta;A. Boddie;A. Constantinou]
通讯作者: G. Salti;S. Grewal;R. Mehta;T. K. Das Gupta;A. Boddie;A. Constantinou
Resistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.
人白血病 HL-60 细胞对依托泊苷的耐药性:与拓扑异构酶 II 磷酸肽低磷酸化相关的药物诱导的 DNA 裂解减少。
DOI: --
发表时间: 1996
期刊: Molecular pharmacology.
影响因子: --
作者: [Ganapathi,R, Constantinou,A, Kamath,N, Dubyak,G, Grabowski,D, Krivacic,K]
通讯作者: Krivacic,K
Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation.
小鼠红白血病细胞的红细胞分化是通过拓扑异构酶 II α 磷酸化的改变来控制的。
DOI: --
发表时间: 1996
期刊: Cancer research
影响因子: 11.2
作者: [Constantinou,AI, Vaughan,AT, Yamasaki,H, Kamath,N]
通讯作者: Kamath,N
A novel use for the comet assay: detection of topoisomerase II inhibitors.
彗星试验的新用途:检测拓扑异构酶 II 抑制剂。
DOI: --
发表时间: 2000
期刊: Anticancer research.
影响因子: --
作者: [Salti,GI, DasGupta,TK, Constantinou,AI]
通讯作者: Constantinou,AI
Mechanism(s)of antitumor action of tamoxifen and soy
  • 批准号:
    6411779
  • 项目类别:
  • 资助金额:
    $44.02万
  • 财政年份:
    2001
  • 负责人:
    ANDREAS I. CONSTANTINOU
  • 依托单位:
Mechanism(s)of antitumor action of tamoxifen and soy
  • 批准号:
    6658979
  • 项目类别:
  • 资助金额:
    $45.95万
  • 财政年份:
    2001
  • 负责人:
    ANDREAS I. CONSTANTINOU
  • 依托单位:
CHEMOPREVENTION OF MAMMARY TUMORS BY TAMOXIFEN AND SOY
  • 批准号:
    6401157
  • 项目类别:
  • 资助金额:
    $7.79万
  • 财政年份:
    2001
  • 负责人:
    ANDREAS I. CONSTANTINOU
  • 依托单位:
CHEMOPREVENTION OF MAMMARY TUMORS BY TAMOXIFEN AND SOY
  • 批准号:
    6515233
  • 项目类别:
  • 资助金额:
    $7.79万
  • 财政年份:
    2001
  • 负责人:
    ANDREAS I. CONSTANTINOU
  • 依托单位:
海外基金